# Shandong Qilu King-phar Pharmaceutical Co., Ltd. – FDA Inspection, Sep 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/shandong-qilu-king-phar-pharmaceutical-co-ltd/d75c788e-0a02-4de6-a4cf-001c5de4cd8b
Source feed: FDA_Inspections

> FDA inspection 1220963 of Shandong Qilu King-phar Pharmaceutical Co., Ltd., September 15, 2023. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220963
- Company Name: Shandong Qilu King-phar Pharmaceutical Co., Ltd.
- Inspection Date: 2023-09-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Monitoring of Marketed Animal Drugs, Feed, and Devices
- Product Type: Veterinary
- Center: Animal Drugs & Feeds
- Office Name: Center for Veterinary Medicine
- Citation Count: 0

## Related Documents

- FDA Inspection 1009139 - 2017-03-24
- FDA Inspection 928475 - 2015-04-24
- FDA Inspection 738711 - 2011-08-04

## Related Officers

- [Carolina D. Vasquez](https://www.keypedia.com/people/carolina-d-vasquez/ffa9d542-e660-4575-831e-f11a2de4b978)
- [FDA Associated Person](https://www.keypedia.com/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)

Company: https://www.keypedia.com/companies/shandong-qilu-king-phar-pharmaceutical-co-ltd/6f6df71b-c004-4e18-a7c0-6e5469a8c6b3

Office: https://www.keypedia.com/offices/center-for-veterinary-medicine/7e30a309-56e4-4e7a-8b8b-e07674bb07b4
